HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumer Health Goliaths Face Proposed US Class Actions For ‘Natural’ ChapStick, Selsun Blue Claims

Executive Summary

Plaintiffs take aim at Pfizer and GlaxoSmithKline in California federal court for “natural” ChapStick claims, while Sanofi US is defending the naturalness of Selsun Blue Naturals Antidandruff Shampoo in New York’s Eastern District.

You may also be interested in...



Are ‘Natural’ Claims Equivalent To ‘All Natural’? Tarte’s $1.7m Settlement Offers Little Instruction

Tarte admits no wrongdoing in its settlement with nationwide purchasers of its “high performance naturals,” and it put up little fight in order to minimize costs. Insight remains limited as to whether federal courts agree with plaintiffs that general “natural” claims on cosmetic products – as opposed to “all natural” or “100% natural” assertions – mean no synthetic ingredients at all.

GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes

Under Brian McNamara’s leadership, GSK Consumer Healthcare has begun to assemble a management team that combines talent from both GSK and Pfizer.

FTC Final Revised “Green Guides” Tackle Certification Disclosures

FTC’s final revised “Green Guides” urge companies to disclose material connections to third-party certifiers when touting environmental seals on products, among other recommendations. While not legally binding, the guides are intended to help firms avoid FTC enforcement action.

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel